Brief: Gap Says Outlook FY Net Sales Up 1% To 1.5% VS Prior Forecast Up 1% To 2%
BRIEF-Gap Says Outlook FY Net Sales Up 1% To 1.5% VS Prior Forecast Up 1% To 2% Aug 27 (Reuters) - The Gap, Inc. GAP.N:
GAP INC Q2 ADJ EPS $0.52 VS IBES ESTIMATE $0.48
GAP INC Q2 COMPARABLE SALES DOWN 1%
GAP INC Q2 SALES $3.65 BLN VS IBES ESTIMATE $3.69 BLN
GAP INC: GOT REFUNDS OF $95 MLN & RELATED INTEREST INCOME OF $5 MLN IN Q2, WITH REMAINING REFUNDS & RELATED INTEREST INCOME EXPECTED IN Q3
GAP INC: IN Q2, RECORDED $417 MLN ADJUSTMENT TO COST OF GOODS SOLD RELATED TO NET IEEPA TARIFF RECOVERY
GAP INC OUTLOOK FY NET SALES UP 1% TO 1.5% VS PRIOR FORECAST UP 1% TO 2%
GAP INC OUTLOOK Q3 NET SALES UP 1.5% TO 2.5%
GAP INC OUTLOOK Q3 GROSS MARGIN UP ABOUT 25 TO 75 BASIS POINTS
GAP INC OUTLOOK FY ADJ EPS ABOUT $2.35 TO $2.45 VS PRIOR FORECAST ABOUT $2.30 TO $2.40
GAP INC: ANNOUNCES MICHAEL FRANCIS AS OLD NAVY'S NEXT PRESIDENT & CEO, SUCCEEDING HAIO BARBEITO
THE GAP, INC. GAP.N FY SHR VIEW $2.34, REV VIEW $15.53 BLN -- LSEG IBES DATA
GAP INC OUTLOOK FY ADJ GROSS MARGIN UP SLIGHTLY YOY
Further company coverage: GAP.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on The Gap
See all newsAmerican Eagle shares slump on flat margin outlook, weakness in namesake brand (updated)
American Eagle shares slide as flat margin outlook, weak core brand weigh
Street View: Gap shines despite Old Navy stumble
U.S. STOCKS ON THE MOVE-Bleichroeder Acquisition Corp, Halliburton, BioNTech
U.S. STOCKS ON THE MOVE-Halliburton, BioNTech, Kazia Therapeutics